Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level903 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06578052 | Irinotecan Liposome in Combination With Capecitabine | recruiting | N/A | 20 | Junjie HangOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT04136132 | Prospective Monocentric Clinical-biological Database(BCBPancréas) | recruiting | N/A | 120 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06144762 |
| Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer(PANC-O-MICS) |
| recruiting |
| N/A |
| 150 |
| Institut du Cancer de Montpellier - Val d'AurelleOTHER |
| 1 |
| Feb 12, 2025 |
| clinicaltrials |
| NCT06800469 | Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer | recruiting | N/A | 30 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT05851534 | Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas(PROMISE-P) | recruiting | N/A | 2,575 | Maastricht University Medical CenterOTHER | 1 | Oct 26, 2024 | clinicaltrials |
| NCT06649474 | Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1(HEPATOXALI) | recruiting | N/A | 100 | University Hospital, Clermont-FerrandOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT06632886 | AI-Assisted Non-Contrast CT for Multi-Cancer Screening | recruiting | N/A | 1,000,000 | Guo ShiWeiOTHER | 1 | Oct 9, 2024 | clinicaltrials |
| NCT04571294 | Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy(PALN) | recruiting | N/A | 180 | Humanitas Hospital, ItalyOTHER | 1 | Oct 4, 2024 | clinicaltrials |
| NCT04498767 | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)(OligoRARE) | recruiting | N/A | 200 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Aug 26, 2024 | clinicaltrials |
| NCT06541340 | A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice(PROB) | recruiting | N/A | 360 | Ruijin HospitalOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT06349278 | Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX(PDAC-LIV) | recruiting | N/A | 15 | Laval UniversityOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT06361316 | Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer | recruiting | N/A | 53 | Kuirong JiangOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT06340620 | EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope | recruiting | N/A | 140 | Orlando Health, Inc.OTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT04575363 | RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer(PaCaBioMarkeR) | recruiting | N/A | 90 | CHU de ReimsOTHER | 1 | Nov 9, 2023 | clinicaltrials |
| NCT06065891 | Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer(PALN) | recruiting | N/A | 300 | Jon UnossonOTHER | 2 | Oct 4, 2023 | clinicaltrials |
| NCT05869474 | Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma | recruiting | N/A | 206 | Changhai HospitalOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT05802394 | The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer(MAP-03) | recruiting | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05802407 | The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer(MAP-02) | recruiting | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05620732 | Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T | recruiting | N/A | 20 | Shenzhen University General HospitalOTHER | 1 | Nov 22, 2022 | clinicaltrials |
| NCT03747588 | The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer(MIOPP) | recruiting | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT03785743 | Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma | recruiting | N/A | 200 | Tongji HospitalOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT03787056 | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients(ONCOPRO) | recruiting | N/A | 410 | Hospices Civils de LyonOTHER | 1 | Jul 16, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Feb 14, 2025source: clinicaltrials